Press Releases

Featured Press Releases

New Report Outlines Best Practices in Bioscience…

Today, the Biotechnology Innovation Organization (BIO), in partnership with the Council of State Bioscience Associations (CSBA), released a new report on bioscience economic development best practices, “Driving the Bioscience Economy Forward During…

Learn more

CMS’ Attempt to Restrict Patient Access to…

Dr. Michelle McMurry-Heath, president and CEO of the Biotechnology Innovation Organization (BIO), released the following statement in response to the Centers for Medicare and Medicaid Services’ (CMS) proposed National Coverage Determination (NCD) to…

Learn more

"Build Back Better Act" Drug Pricing Provisions…

Dr. Michelle McMurry-Heath, president and CEO of the Biotechnology Innovation Organization (BIO), released the following statement after the House of Representatives passed the Build Back Better Act: “The legislation that passed the House today…

Learn more

New Report Outlines Best Practices in Bioscience Economic Development Initiatives

January 20, 2022

CMS’ Attempt to Restrict Patient Access to Alzheimer’s Drug Sets “Dangerous and Far-Reaching” Precedent

January 13, 2022

"Build Back Better Act" Drug Pricing Provisions Weaken U.S. Innovation Ecosystem, Hurt Patients

November 19, 2021

Patients Empowered with New “Clinical Trials: The Power of Participation” Website

November 16, 2021

The Biotechnology Innovation Organization (BIO) today announced the launch of Clinical Trials: The Power of Participation (CTPoP), a website that addresses how clinical trials work, how to enroll in a clinical trial, and what to expect as a clinical…

White House’s “Build Back Better” Plan Builds New Barriers for Patients and Scientists Discovering Groundbreaking Cures

November 4, 2021

Dr. Michelle McMurry-Heath, President and CEO of the Biotechnology Innovation Organization (BIO), made the following statement: "Last week, Democratic leaders announced they had reached a drug pricing “deal.” We wanted to see the details before…

Proposed Prescription Drug User Fee Act VII Performance Goals Letter Earns BIO Support

August 24, 2021

Biotechnology Innovation Organization (BIO) Chief Scientific Officer, E. Cartier Esham issued the following statement on the release of the Prescription Drug User Fee Act (PDUFA) VII performance goals letter: “The Prescription Drug User Fee…

Biden Drug Plan Adds Barriers to Seniors Accessing Lifesaving Medicines

August 12, 2021

President Joe Biden today announced a slew of drug pricing reforms, including changes that would radically alter the widely successful Medicare program for seniors and people with disabilities. Rich Masters, BIO’s Chief Public Affairs and Advocacy…

BIO Announces 2021 Start-up Stadium Winner: Kayothera Inc.

July 27, 2021

Annual competition takes place during BIO’s International Convention

BIO Promotes Sarah Gallo to Vice President, Agriculture and Environment

July 22, 2021

The Biotechnology Innovation Organization (BIO) is pleased to announce today the promotion of Sarah Gallo to Vice President, Agriculture and Environment. In her new role, Sarah will lead the policy and market access strategies for BIO’s Agriculture…

BIO Cheers Senate Passage of Growing Climate Solutions Act

June 24, 2021

Dr. Michelle McMurry-Heath, president and CEO of the Biotechnology Innovation Organization (BIO), released the following statement after the Senate passed the Growing Climate Solutions Act: “This bill is at the heart of everything we fight…

Daily News You Can’t Afford to Miss

Read it in under 3 minutes!

The Good Day BIO newsletter is the only daily newsletter at the intersection of biotech, politics, and policy.